Pay in 4 interest-free payments of $5.07 Learn more
Ships within 48 hours · Estimated delivery Aug 15 - Aug 20
Liraglutide, a once-daily human GLP-1 analogue, added to a sulphonylurea over 26 weeks produces greater improvements in glycaemic and weight control compared with adding rosiglitazone or placebo in subjects with type 2 diabetes (LEAD-1 SU)
Losing weight is an enriching experience for a wide array of reasons
BMC Bioinformatics 11 , 119 (2010)
For most people, the study authors conclude that the proven benefits of GLP-1 drugs for those with type 2 diabetes, such as improvements in blood glucose control, weight loss, and reductions in cardiovascular and kidney disease risk, outweigh this potential safety signal
US$ 27.23
US$ 28.24
US$ 25.48
US$ 26.97
US$ 22.97
US$ 21.70
US$ 26.85
US$ 23.68
US$ 20.42
US$ 25.83
US$ 24.61
US$ 21.64
